SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.28-0.1%12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: manfredhasler who wrote (14558)9/16/2000 11:04:15 AM
From: Robert K.  Read Replies (2) of 17367
 
Manfred, you are wrong...your comment"My problem is that the placebo group has only 9.9% mortality. The delay in treatment with the study drug does not affect the placebo arm."

My comment> most of kids that "would have " died ,did so BEFORE they could even be admitted to the trial. Therefore
the 9.9% placebo number is very misleading. Unfortunatly
the trial design did not allow for a speedy adminitration of bpi. For the drug to show effectiveness more kids must die. Think about that please. That IMO is sick.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext